0000724445
us-gaap:EmployeeStockOptionMember
2009-06-01
2009-06-01
0000724445
us-gaap:RetainedEarningsMember
2018-02-28
0000724445
us-gaap:AdditionalPaidInCapitalMember
2018-02-28
0000724445
us-gaap:RetainedEarningsMember
2017-02-28
0000724445
us-gaap:AdditionalPaidInCapitalMember
2017-02-28
0000724445
us-gaap:RetainedEarningsMember
2016-02-29
0000724445
us-gaap:AdditionalPaidInCapitalMember
2016-02-29
0000724445
us-gaap:CommonStockMember
2018-02-28
0000724445
us-gaap:CommonStockMember
2017-02-28
0000724445
us-gaap:CommonStockMember
2016-02-29
0000724445
us-gaap:EmployeeStockOptionMember
1998-06-01
1998-06-01
0000724445
us-gaap:EmployeeStockOptionMember
1997-06-01
1997-06-01
0000724445
us-gaap:EmployeeStockOptionMember
1996-09-14
1996-09-14
0000724445
bzyr:FurnitureAndEquipmentMember
us-gaap:MinimumMember
2017-03-01
2018-02-28
0000724445
bzyr:FurnitureAndEquipmentMember
us-gaap:MaximumMember
2017-03-01
2018-02-28
0000724445
bzyr:FurnitureAndEquipmentMember
2018-02-28
0000724445
bzyr:FurnitureAndEquipmentMember
2017-02-28
0000724445
bzyr:OperatingLossCarryfowardsExpirationPeriod2037Member
2018-02-28
0000724445
bzyr:OperatingLossCarryforwardsExpirationPeriod2034Member
2018-02-28
0000724445
bzyr:OperatingLossCarryforwardsExpirationPeriod2033Member
2018-02-28
0000724445
bzyr:OperatingLossCarryforwardsExpirationPeriod2029Member
2018-02-28
0000724445
bzyr:OperatingLossCarryforwardsExpirationPeriod2028Member
2018-02-28
0000724445
bzyr:OperatingLossCarryforwardsExpirationPeriod2027Member
2018-02-28
0000724445
bzyr:OperatingLossCarryforwardsExpirationPeriod2026Member
2018-02-28
0000724445
bzyr:OperatingLossCarryforwardsExpirationPeriod2025Member
2018-02-28
0000724445
bzyr:OperatingLossCarryforwardsExpirationPeriod2024Member
2018-02-28
0000724445
bzyr:OperatingLossCarryforwardsExpirationPeriod2023Member
2018-02-28
0000724445
bzyr:OperatingLossCarryforwardsExpirationPeriod2022Member
2018-02-28
0000724445
us-gaap:RetainedEarningsMember
2017-03-01
2018-02-28
0000724445
us-gaap:RetainedEarningsMember
2016-03-01
2017-02-28
0000724445
us-gaap:MinimumMember
2017-03-01
2018-02-28
0000724445
us-gaap:MaximumMember
2017-03-01
2018-02-28
0000724445
2018-01-01
2018-02-28
0000724445
2017-03-01
2017-12-31
0000724445
bzyr:FourSuppliersMember
us-gaap:CostOfGoodsTotalMember
us-gaap:SupplierConcentrationRiskMember
2017-03-01
2018-02-28
0000724445
bzyr:ThreeSuppliersMember
us-gaap:CostOfGoodsTotalMember
us-gaap:SupplierConcentrationRiskMember
2016-03-01
2017-02-28
0000724445
2016-02-29
0000724445
2017-02-28
0000724445
2017-08-31
0000724445
2018-05-01
0000724445
bzyr:WorldwideMedicalConsultantsIncMember
bzyr:CarigenLtdMember
2012-07-05
0000724445
us-gaap:EmployeeStockOptionMember
2017-03-01
2018-02-28
0000724445
us-gaap:EmployeeStockOptionMember
2016-03-01
2017-02-28
0000724445
bzyr:MinimumEssentialCoverageMember
us-gaap:MinimumMember
2017-03-01
2018-02-28
0000724445
bzyr:MinimumEssentialCoverageMember
us-gaap:MaximumMember
2017-03-01
2018-02-28
0000724445
us-gaap:MaximumMember
bzyr:MajorityShareholderAndPresidentMember
us-gaap:RoyaltyAgreementsMember
2017-03-01
2018-02-28
0000724445
bzyr:MajorityShareholderAndPresidentMember
us-gaap:RoyaltyAgreementsMember
2017-03-01
2018-02-28
0000724445
country:MX
us-gaap:LicensingAgreementsMember
2017-03-01
2018-02-28
0000724445
country:CA
us-gaap:LicensingAgreementsMember
2017-03-01
2018-02-28
0000724445
bzyr:MajorityShareholderAndPresidentMember
us-gaap:ResearchAndDevelopmentArrangementMember
2017-03-01
2018-02-28
0000724445
bzyr:MajorityShareholderAndPresidentMember
us-gaap:LicensingAgreementsMember
2017-03-01
2018-02-28
0000724445
country:US
us-gaap:LicensingAgreementsMember
2017-03-01
2018-02-28
0000724445
us-gaap:MinimumMember
bzyr:MajorityShareholderAndPresidentMember
us-gaap:ResearchAndDevelopmentArrangementMember
2017-03-01
2018-02-28
0000724445
us-gaap:MaximumMember
bzyr:MajorityShareholderAndPresidentMember
us-gaap:ResearchAndDevelopmentArrangementMember
2017-03-01
2018-02-28
0000724445
bzyr:FourSuppliersMember
2017-03-01
2018-02-28
0000724445
bzyr:ThreeSuppliersMember
2016-03-01
2017-02-28
0000724445
bzyr:WorldwideMedicalConsultantsIncMember
bzyr:CarigenLtdMember
2017-03-01
2018-02-28
0000724445
bzyr:WorldwideMedicalConsultantsIncMember
bzyr:CarigenLtdMember
2018-02-28
0000724445
bzyr:WorldwideMedicalConsultantsIncMember
bzyr:CarigenLtdMember
2012-07-05
2012-07-05
0000724445
2018-02-28
0000724445
us-gaap:AdditionalPaidInCapitalMember
2017-03-01
2018-02-28
0000724445
bzyr:MajorityShareholderAndPresidentMember
2017-03-01
2018-02-28
0000724445
2017-03-01
2018-02-28
0000724445
us-gaap:AdditionalPaidInCapitalMember
2016-03-01
2017-02-28
0000724445
bzyr:MajorityShareholderAndPresidentMember
2016-03-01
2017-02-28
0000724445
2016-03-01
2017-02-28
iso4217:USD
xbrli:shares
iso4217:USD
bzyr:item
xbrli:pure
bzyr:item
xbrli:shares
iso4217:USD
311943
311943
311943
319268
319268
319268
42603
-2572
-225
P10Y
0
0
1260791
1218134
0
3
4
0
0.810
0.10
1000000
P30D
5
34
2
4
1
8
0.10
1000
1000
0.50
P1Y
0.10
1000000
2554
0
0
0
0
0
1000000
1
1500
-112401
0.16
107700
false
--02-28
FY
2018
2018-02-28
10-K
0000724445
131448444
Yes
Smaller Reporting Company
1273735
BURZYNSKI RESEARCH INSTITUTE INC
No
No
19652
41941
24080
94688
22415
22415
118609079
120146481
1260791
1260791
1260791
1218134
1218134
1218134
1600000
1600000
10731
28929
10731
28929
3303
731
506
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-style:italic;font-size:10pt;">Cash and Cash Equivalents</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
0.10
2000000
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-size:10pt;">8.</font><font style="display:inline;font-size:3pt;"> </font><font style="display:inline;font-weight:bold;font-size:10pt;">Commitments and Contingencies and Supply Source:</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">In the ordinary course of conducting business, the Company may be a party to legal proceedings and claims. As of February 28, 2018, the Company does not expect the final outcome of any such matters to have a material adverse effect on its financial position, results of operations, or cash flows.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">As described in Note 2, the Company entered a Royalty Agreement with Dr. Burzynski. Under that agreement, upon FDA approval, the Company is obligated to provide Dr. Burzynski the right to produce Antineoplaston products to treat up to 1,000 patients without paying any fees to the Company or the right to purchase Antineoplaston products to treat up to 1,000 patients at cost plus 10%. As such, Dr. Burzynski supplies all of the Antineoplaston products to the Company.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">No patients were treated during the year ended February 28, 2018, and one patient was treated at the Burzynski Research Clinic during the year ended February 28, 2017. Management estimates the current production facilities have the capacity to produce product to treat approximately 1,500 patients per year. There is space available at the current site to expand the facility for increased capacity if necessary.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company received approximately 86% of the chemicals used in producing Antineoplastons from four suppliers during the year ended February 28, 2018 and 74% from three suppliers during the year ended February 28, 2017. Dr. Burzynski has established additional vendors to supply these chemicals should there be a loss of these suppliers.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
0.001
0.001
200000000
200000000
131448444
131448444
131448444
131448444
131449
131449
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;text-indent: -36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-size:10pt;">4.</font><font style="display:inline;font-size:3pt;"> </font><font style="display:inline;font-weight:bold;font-size:10pt;">Employee Benefits:</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Through December 31, 2017, employees of SRB received health care benefits as well as group dental insurance, vision, short-term and long-term disability insurance, and life insurance, under both HMO and PPO options from which employees could choose coverage. Effective January 1, 2018, only PPO options are offered to employees. Employees pay pre-tax premiums from $0 to $2,554 per month depending upon the insurance coverage selected by the employee.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company had a self-funded plan prior to July 1, 2014, and thus certain claims filed under that plan that were incurred prior to this date continue to be presented to the Company for payment and are expected to decrease over time. The Company charged to operations a provision of $41,213 for 2018 and $28,875 for 2017, which represents the sum of actual claims paid and an estimate of liabilities relating to claims, both asserted and unasserted, resulting from incidents that occurred during the year. These amounts include costs related to employees of SRB that have been allocated to the Company.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
0.74
0.86
242202
181572
199599
138969
42603
42603
242202
181572
28875
41213
684
0
-0.01
-0.01
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-style:italic;font-size:10pt;">Loss Per Common Share</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company accounts for loss per share in accordance with FASB ASC 260, </font><font style="display:inline;font-style:italic;font-size:10pt;">Earnings per Share</font><font style="display:inline;font-size:10pt;">. Basic loss per share amounts are calculated by dividing net loss by the weighted average number of common shares outstanding during each period. Diluted loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding for the periods, including the dilutive effect of all common stock equivalents. Dilutive options and warrants that are issued during a period or that expire or are canceled during a period are reflected in the computations for the time they were outstanding during the periods being reported. During the years ended February 28, 2018 and 2017, 1,600,000 warrants and stock options were excluded from the calculation of diluted loss per share because their effect would be anti-dilutive.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
0.34
0.21
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 22.5pt;text-indent:13pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-style:italic;font-size:10pt;">Fair Value of Financial Instruments</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;text-indent: -0.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The carrying value of cash and accounts payable approximates fair value due to the short term maturity of these instruments. None of the financial instruments are held for trading purposes.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
179072
332631
-1504717
-1612101
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-size:10pt;">6.</font><font style="display:inline;font-size:3pt;"> </font><font style="display:inline;font-weight:bold;font-size:10pt;">Income Taxes:</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;text-indent:0.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The costs incurred related to the conduct of FDA approved clinical trials incurred directly by Dr. Burzynski within his medical practice are deducted by Dr. Burzynski and are not included in the Company’s tax provision.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Under the Tax Cuts and Jobs Act of 2017, the federal tax rates in effect starting in 2018, affecting future tax benefits, went from 34% to 21%. The change in the enacted rate did not have an effect on the Company’s income tax expense for the year ended February 28, 2018 as a valuation allowance has been recorded for the total deferred tax assets. The valuation allowance decreased by $112,401 due to the change in the enacted rate. The actual income tax benefit attributable to the Company’s losses for the years ended February 28, 2018 and 2017 differ from the amounts computed by applying the U.S. federal income tax rate of 21% and 34%, respectively, to the pretax loss as a result of the following:</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 86.00%;margin-left:36pt;">
<tr>
<td valign="bottom" style="width:65.40%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-size:8pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">2018</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">2017</font></p>
</td>
<td valign="bottom" style="width:01.16%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Expected benefit</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.54%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(338,541
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">)</font></p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.54%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(511,604
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">)</font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Effect of expenses deducted directly by Dr. Burzynski</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>338,541
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>511,604
</td>
<td valign="bottom" style="width:01.16%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Other adjustments</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(60,630
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">)</font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>23,128
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Change in valuation allowance</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>60,630
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(23,128
</td>
<td valign="bottom" style="width:01.16%;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">)</font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.16%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Income tax expense</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.54%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.54%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
</tr>
</table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The components of the Company’s deferred income tax assets as of February 28, 2018 and 2017 are as follows:</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 86.00%;margin-left:36pt;">
<tr>
<td valign="bottom" style="width:65.40%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-size:8pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">2018</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">2017</font></p>
</td>
<td valign="bottom" style="width:01.16%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Deferred tax assets:</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Net operating loss carryforwards</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.54%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>138,969
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.54%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>199,599
</td>
<td valign="bottom" style="width:01.16%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Excess book (tax) depreciation</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Accrued expenses</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:01.16%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Alternative minimum tax credit carryforwards</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>42,603
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>42,603
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Total deferred tax assets</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>181,572
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>242,202
</td>
<td valign="bottom" style="width:01.16%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Less valuation allowance</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(181,572
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">)</font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(242,202
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">)</font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Net deferred tax assets</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.54%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.54%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:01.16%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.16%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
</tr>
</table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company’s ability to utilize net operating loss carryforwards and alternative minimum tax credit carryforwards will depend on its ability to generate adequate future taxable income. The Company has no historical earnings on which to base an expectation of future taxable income. Accordingly, a valuation allowance for the total deferred tax assets has been provided.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company has net operating loss carryforwards available to offset future income in the amount of $661,756 as of February 28, 2018. The net operating loss carryforwards expire as of February 28 or 29 of the following years:</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 35.00%;margin-left:36pt;">
<tr>
<td valign="top" style="width:32.04%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2022</font></p>
</td>
<td valign="bottom" style="width:06.98%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,250
</td>
<td valign="bottom" style="width:05.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:32.04%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2023</font></p>
</td>
<td valign="bottom" style="width:06.98%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>73,401
</td>
<td valign="bottom" style="width:05.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:32.04%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2024</font></p>
</td>
<td valign="bottom" style="width:06.98%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>69,394
</td>
<td valign="bottom" style="width:05.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:32.04%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2025</font></p>
</td>
<td valign="bottom" style="width:06.98%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>13,475
</td>
<td valign="bottom" style="width:05.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:32.04%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2026</font></p>
</td>
<td valign="bottom" style="width:06.98%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>46,972
</td>
<td valign="bottom" style="width:05.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:32.04%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2027</font></p>
</td>
<td valign="bottom" style="width:06.98%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>31,220
</td>
<td valign="bottom" style="width:05.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:32.04%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2028</font></p>
</td>
<td valign="bottom" style="width:06.98%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,737
</td>
<td valign="bottom" style="width:05.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:32.04%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2029</font></p>
</td>
<td valign="bottom" style="width:06.98%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>31,868
</td>
<td valign="bottom" style="width:05.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:32.04%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2030</font></p>
</td>
<td valign="bottom" style="width:06.98%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:05.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:32.04%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2031</font></p>
</td>
<td valign="bottom" style="width:06.98%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:05.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:32.04%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2032</font></p>
</td>
<td valign="bottom" style="width:06.98%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:05.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:32.04%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2033</font></p>
</td>
<td valign="bottom" style="width:06.98%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>207,097
</td>
<td valign="bottom" style="width:05.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:32.04%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2034</font></p>
</td>
<td valign="bottom" style="width:06.98%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>76,643
</td>
<td valign="bottom" style="width:05.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:32.04%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2035</font></p>
</td>
<td valign="bottom" style="width:06.98%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:05.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:32.04%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2036</font></p>
</td>
<td valign="bottom" style="width:06.98%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:05.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:32.04%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2037</font></p>
</td>
<td valign="bottom" style="width:06.98%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>74,699
</td>
<td valign="bottom" style="width:05.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
</table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">In addition, the Company has alternative minimum tax credit carryforwards of $42,603 at February 28, 2018.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
400
400
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-style:italic;font-size:10pt;">Income Taxes</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;text-indent:0.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company uses the asset and liability method of accounting for income taxes, under which deferred income taxes are recognized for the tax consequences of temporary differences by applying the enacted statutory tax rate applicable to future years to differences between financial statement carrying amounts and the tax basis of existing assets and liabilities.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;text-indent:0.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. The costs incurred related to the conduct of FDA approved clinical trials incurred directly by Dr. Burzynski within his medical practice are deducted by Dr. Burzynski and are not included in the Company’s tax provision. The portion of the Texas gross margin tax that is based on income is treated as income taxes and included in the income tax provision.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;text-indent:0.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 740-10, </font><font style="display:inline;font-style:italic;font-size:10pt;">Accounting for Uncertainty in Income Taxes</font><font style="display:inline;font-size:10pt;">, clarifies the accounting for income taxes by prescribing the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. ASC 740-10 also provides guidance on derecognition, measurement, classification, interest and penalties, accounting during interim periods, disclosure, and transition. For the years ended February 28, 2018 and 2017, no uncertain tax positions were identified.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
-23128
60630
511604
338541
-511604
-338541
23128
-60630
-44741
22289
-16532
70608
10000
-10000
28423
81688
31471
258159
154506
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-size:10pt;">5.</font><font style="display:inline;font-size:3pt;"> </font><font style="display:inline;font-weight:bold;font-size:10pt;">Lease commitments:</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Dr. Burzynski leases certain equipment used in the clinical trials under leases originally maturing in one to four years. Rent expense incurred under these leases was approximately $69,978 and $89,229 for the years ended February 28, 2018 and 2017, respectively.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">As explained in Note 2, Dr. Burzynski owns the facility used by the Company to perform research and produce its drug products. There is currently no lease agreement; however, the facility’s costs are included in the accompanying financial statements as rental expense. The rental expense is derived from not only utilities and expenses normally incurred by a tenant but also mortgage interest, insurance, property taxes and building depreciation. Rent expense totaled $154,506 and $258,159 for 2018 and 2017, respectively.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
P4Y
P1Y
43732
136629
10731
28929
43732
136629
311943
319268
-314515
-319493
-1504717
-1504717
-1612101
-1612101
1504717
1613101
-1504717
-1613101
89229
69978
661756
29250
73401
69394
13475
46972
31220
7737
31868
207097
76643
74699
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-size:10pt;">1.</font><font style="display:inline;font-size:3pt;"> </font><font style="display:inline;font-weight:bold;font-size:10pt;">Background, Basis of Presentation, Economic Dependency and Significant Accounting</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-size:10pt;">Policies:</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;text-indent:35.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-size:10pt;text-decoration:underline;">Background and Basis of Presentation</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The financial statements of Burzynski Research Institute, Inc. (the “Company” or “BRI”), a Delaware corporation, include expenses incurred related to clinical trials, which were sanctioned by the U.S. Food and Drug Administration (FDA) in 1993, for Antineoplaston drugs used in the treatment of cancer. These expenses are incurred directly by S.R. Burzynski, M.D., Ph.D. (Dr. Burzynski or “SRB”) on behalf of the Company and have been reported as research and development costs and as additional paid-in capital. Other funds received from Dr. Burzynski have also been reported as additional paid-in capital. Expenses related to Dr. Burzynski’s medical practice (unrelated to the clinical trials) have not been included in these financial statements. Dr. Burzynski is the President, Chairman of the Board and owner of over 81.0% of the outstanding common stock of the Company, and also is the inventor and original patent holder of certain drug products known as “Antineoplastons,” which he has licensed to the Company.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;text-indent:0.7pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company and Dr. Burzynski have entered into various agreements, as further described in Note 2, which provide the Company the exclusive right in the United States, Canada and Mexico to use, manufacture, develop, sell, distribute, sublicense and otherwise exploit all the rights, titles and interest in Antineoplaston drugs used in the treatment of cancer, once the drug is approved for sale by the FDA.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company is primarily engaged as a research and development facility for Antineoplaston drugs being tested for the use in the treatment of cancer. The Company’s IND 43742 is currently under full clinical hold and the Company cannot enroll new patients into any clinical trials until the full clinical hold is removed by the FDA. At this time, none of the Antineoplaston drugs have received FDA approval; further, there can be no assurance that FDA approval will be granted.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;text-indent:0.7pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">BRI’s administrative offices are located in Houston, Texas; its research and production facilities are in Stafford, Texas. The Company operates primarily as a research and development facility of Antineoplaston drugs currently being tested for the use in the treatment of cancer, and provides consulting services. Segment information is not presented since all of the Company’s operations are attributed to a single reportable segment. The Company has had no significant revenue from external sources. The Company is currently conducting clinical trials on various Antineoplastons in accordance with FDA regulations, however, at this time none of the Antineoplaston drugs have received FDA approval; further, there can be no assurance FDA approval will be granted.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-size:10pt;text-decoration:underline;">Economic Dependency</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">BRI has generated no significant revenues since its inception. As of February 28, 2018, the Company had a working capital deficit of approximately $107,700 and accumulated deficit of approximately $120,386,000. For the years ended February 28, 2018 and 2017, the Company incurred losses of approximately $1,600,000 and $1,500,000, respectively.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Dr. Burzynski has funded the capital and operational needs of the Company since its inception from revenues generated through his medical practice pursuant to various agreements as described in Note 2.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company is economically dependent on its funding from Dr. Burzynski through his medical practice. In the past, a portion of Dr. Burzynski’s patients have been admitted and treated as part of the clinical trial programs. The Company’s IND 43742 is currently under full clinical hold and the Company cannot enroll new patients into any clinical trials until the full clinical hold is removed by the FDA. The FDA imposes numerous regulations and requirements’ regarding these patients and the Company is subject to inspection at any time by the FDA. These regulations are complex and subject to interpretation and though it is management’s intention to comply fully with all such regulations, there is the risk that the Company is not in compliance and is thus subject to sanctions imposed by the FDA.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">In addition, as with any medical practice, Dr. Burzynski is subject to potential claims by patients and other potential claimants commonly arising out of the operation of a medical practice. The risks associated with Dr. Burzynski’s medical practice directly affect his ability to fund the operations of BRI.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-size:10pt;text-decoration:underline;">Significant Accounting Policies</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-style:italic;font-size:10pt;">Cash and Cash Equivalents</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-style:italic;font-size:10pt;">Property and Equipment</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;text-indent:0.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Property and equipment are recorded at cost and depreciated using the straight-line method over the estimated useful lives of the assets, which range from 5 to 10 years. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized; maintenance and repairs are charged against earnings as incurred. Upon disposal of assets, the related cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized currently in the Statement of Operations.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-style:italic;font-size:10pt;">Income Taxes</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;text-indent:0.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company uses the asset and liability method of accounting for income taxes, under which deferred income taxes are recognized for the tax consequences of temporary differences by applying the enacted statutory tax rate applicable to future years to differences between financial statement carrying amounts and the tax basis of existing assets and liabilities.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;text-indent:0.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. The costs incurred related to the conduct of FDA approved clinical trials incurred directly by Dr. Burzynski within his medical practice are deducted by Dr. Burzynski and are not included in the Company’s tax provision. The portion of the Texas gross margin tax that is based on income is treated as income taxes and included in the income tax provision.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;text-indent:0.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 740-10, </font><font style="display:inline;font-style:italic;font-size:10pt;">Accounting for Uncertainty in Income Taxes</font><font style="display:inline;font-size:10pt;">, clarifies the accounting for income taxes by prescribing the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. ASC 740-10 also provides guidance on derecognition, measurement, classification, interest and penalties, accounting during interim periods, disclosure, and transition. For the years ended February 28, 2018 and 2017, no uncertain tax positions were identified.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-style:italic;font-size:10pt;">Loss Per Common Share</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company accounts for loss per share in accordance with FASB ASC 260, </font><font style="display:inline;font-style:italic;font-size:10pt;">Earnings per Share</font><font style="display:inline;font-size:10pt;">. Basic loss per share amounts are calculated by dividing net loss by the weighted average number of common shares outstanding during each period. Diluted loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding for the periods, including the dilutive effect of all common stock equivalents. Dilutive options and warrants that are issued during a period or that expire or are canceled during a period are reflected in the computations for the time they were outstanding during the periods being reported. During the years ended February 28, 2018 and 2017, 1,600,000 warrants and stock options were excluded from the calculation of diluted loss per share because their effect would be anti-dilutive.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;text-indent:35.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-style:italic;font-size:10pt;">Research and Development</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Research and development cost are charged to operations in the period incurred. Equipment used in research and development activities, which have alternative uses, is capitalized.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 22.5pt;text-indent:13pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-style:italic;font-size:10pt;">Fair Value of Financial Instruments</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;text-indent: -0.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The carrying value of cash and accounts payable approximates fair value due to the short term maturity of these instruments. None of the financial instruments are held for trading purposes.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;text-indent:35.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-style:italic;font-size:10pt;">Management Estimates</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reported periods. The significant estimates are the allocation of payroll and other expenses between the clinical trial expenses reported with BRI and Dr. Burzynski’s medical practice expenses. Department managers review at least quarterly the duties of each employee in their department and estimate the percentage of time each employee spends between clinical trials and the medical practice. Payroll costs are allocated between clinical trials and the medical practice based on these percentages. Other expenses are allocated based on the percentage of payroll allocated to either clinical trials or the medical practice. Management believes that the estimates and allocations are reasonable. Actual results could differ from these estimates.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-style:italic;font-size:10pt;">Stock Options and Warrants</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company accounts for stock-based compensation under the provisions of FASB ASC 718, </font><font style="display:inline;font-style:italic;font-size:10pt;">“Compensation — Stock Compensation,”</font><font style="display:inline;font-size:10pt;"> which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees and non-employee officers based on estimated fair values as of the date of grant. Compensation expense is recognized on a straight-line basis over the requisite service period.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company accounts for share-based payments to non-employees, with guidance provided by FASB ASC 505-50, “</font><font style="display:inline;font-style:italic;font-size:10pt;">Equity-Based Payments to Non-Employees</font><font style="display:inline;font-size:10pt;">.”</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company did not grant any options and no options previously granted vested in any of the periods presented in these financial statements. Thus, there was no effect on net loss and earnings per share regarding the provisions of FASB ASC 718 or FASB 505-50 in any of the periods presented.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
1000
28423
311943
319268
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-size:10pt;">3.</font><font style="display:inline;font-size:3pt;"> </font><font style="display:inline;font-weight:bold;font-size:10pt;">Property and Equipment:</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Property and equipment consists of the following as of February 28, 2018 and 2017, respectively:</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;"><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font></font>
</p>
<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 86.00%;margin-left:36pt;">
<tr>
<td valign="bottom" style="width:48.66%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-size:8pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.90%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">Estimated</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.14%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:48.66%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-size:8pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.90%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">Useful Lives</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">2018</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">2017</font></p>
</td>
<td valign="bottom" style="width:01.14%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:48.66%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Furniture and equipment</font></p>
</td>
<td valign="bottom" style="width:02.90%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:13.84%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">5 - 10 years</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.56%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,415
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.56%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,415
</td>
<td valign="bottom" style="width:01.14%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:48.66%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Total property and equipment</font></p>
</td>
<td valign="bottom" style="width:02.90%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,415
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,415
</td>
<td valign="bottom" style="width:01.14%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:48.66%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Accumulated depreciation</font></p>
</td>
<td valign="bottom" style="width:02.90%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:13.84%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(22,415
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">)</font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(22,415
</td>
<td valign="bottom" style="width:01.14%;background-color: #CCEEFF;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">)</font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:48.66%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.90%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:13.84%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.14%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:48.66%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.90%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.14%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:48.66%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.90%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:13.84%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.56%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.56%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:01.14%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:48.66%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.90%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:13.84%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:12.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:12.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.14%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
</tr>
</table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Depreciation expense for the years ended February 28, 2018 and 2017 was $0 and $684, respectively.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
22415
22415
22415
22415
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-style:italic;font-size:10pt;">Property and Equipment</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;text-indent:0.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Property and equipment are recorded at cost and depreciated using the straight-line method over the estimated useful lives of the assets, which range from 5 to 10 years. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized; maintenance and repairs are charged against earnings as incurred. Upon disposal of assets, the related cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized currently in the Statement of Operations.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;"><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font></font>
</p>
<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 86.00%;margin-left:36pt;">
<tr>
<td valign="bottom" style="width:48.66%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-size:8pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.90%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">Estimated</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.14%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:48.66%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-size:8pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.90%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">Useful Lives</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">2018</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">2017</font></p>
</td>
<td valign="bottom" style="width:01.14%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:48.66%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Furniture and equipment</font></p>
</td>
<td valign="bottom" style="width:02.90%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:13.84%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">5 - 10 years</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.56%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,415
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.56%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,415
</td>
<td valign="bottom" style="width:01.14%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:48.66%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Total property and equipment</font></p>
</td>
<td valign="bottom" style="width:02.90%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,415
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,415
</td>
<td valign="bottom" style="width:01.14%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:48.66%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Accumulated depreciation</font></p>
</td>
<td valign="bottom" style="width:02.90%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:13.84%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(22,415
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">)</font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(22,415
</td>
<td valign="bottom" style="width:01.14%;background-color: #CCEEFF;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">)</font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:48.66%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.90%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:13.84%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.14%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:48.66%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.90%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.14%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:48.66%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.90%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:13.84%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.56%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.56%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:01.14%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:48.66%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.90%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:13.84%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:12.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:12.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.14%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
</tr>
</table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
P10Y
P5Y
P10Y
P5Y
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-size:10pt;">2.</font><font style="display:inline;font-size:3pt;"> </font><font style="display:inline;font-weight:bold;font-size:10pt;">Agreements With, and Other Related Party Transactions:</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company has agreements with its majority shareholder and President Dr. Burzynski as further described below:</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;text-indent:35.25pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;text-decoration:underline;">License Agreement</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Dr. Burzynski is the owner of patents involving the formulation, preparation, manufacture, production, use, dosage and treatment with Antineoplastons. The United States Patent Office and Patent Offices of thirty-four other countries have issued the patents. The Patents for cancer treatment and diagnosis in the United States and Canada are licensed to the Company pursuant to a License Agreement.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display:inline;font-size:10pt;">The License Agreement grants to the Company the exclusive right, in the United States, Canada, and Mexico, to use, manufacture, develop, sell, distribute, sub-license and otherwise exploit all of Dr. Burzynski’s rights, title, and interests, including patent rights, in</font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font></font><font style="display:inline;font-size:3pt;"></font><font style="display:inline;font-size:10pt;">Antineoplaston drugs in the treatment and diagnosis of cancer. The Company will not be able to exploit such rights until such time as Antineoplastons are approved, of which there can be no assurance, by the FDA for sale in the United States and the appropriate authority in Canada and Mexico.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Agreement gives Dr. Burzynski the right to make, use, sell, distribute, and otherwise exploit Antineoplastons in connection with the treatment of patients in his medical practice.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The License Agreement will terminate upon the earlier of the expiration of the last patent licensed to the Company, or termination by Dr. Burzynski, at his option, if he is removed as a director or officer of the Company without his consent, if the Company files for bankruptcy or if any shareholder or group of shareholders acting in concert becomes the beneficial owner of the Company’s securities having voting power equal to or greater than the voting power of the securities Dr. Burzynski holds.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Under the License Agreement, the Company currently owns exclusive rights to eight (8) issued United States Patents, four (4) issued Canadian Patents and one (1) issued Mexican Patent.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"><font style="display:inline;font-size:10pt;">The five initial United States Patents (the “Initial Patents”) relate to: (i) Determination of Antineoplastons in body tissue or fluids as a testing procedure to aid in the diagnosis of cancer; (ii) Processes for the preparation of purified fractions of Antineoplastons from human</font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font></font><font style="display:inline;font-size:3pt;"></font><font style="display:inline;font-size:10pt;">urine; (iii) Processes for the synthetic production of Antineoplastons and methods of treating neoplastic disease (cancer); (iv) Administration of Antineoplastons to humans; and (v) Methods of synthesizing A-10. All of these Initial Patents have expired as of February 28, 2009. The Company does not believe the expiration of any of the Initial Patents will have a material adverse effect on the Company.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The sixth United States Patent (the “2000 U.S. Patent”) covers Liposomal Antineoplaston therapies with markedly improved anti-cancer activity. The 2000 U.S. Patent expired May 14, 2017.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The seventh United States Patent (the “2001 U.S. Patent”) is for a treatment regimen for the administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate. The 2001 U.S. Patent expires on July 23, 2018.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The eighth United States Patent (the “2005 U.S. Patent”) relates to a divisional application to the 2001 U.S. Patent. The 2005 U.S. Patent was issued in September 2005 and expires July 31, 2018.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The four Canadian Patents (the “Canadian Patents”) relate to: (i) Processes for the preparation of purified fractions of Antineoplastons from human urine, (ii) Processes for the synthetic production of Antineoplastons and methods of treating neoplastic disease (cancer), (iii) Liposomal formulation of Antineoplastons and (iv) Treatment regimen for the administration of phenylacetylglutamine. The Canadian Patents expired or will expire on June 4, 2002, November 14, 2006, May 14, 2017, and July 2, 2019, respectively; however, the Company does not believe the Canadian Patents that expired in 2002, 2006, or 2017 will have a material adverse effect on the Company.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Mexican Patent relates to a treatment regimen for the administration of phenylacetylglutamine. This patent will expire January 14, 2019.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;text-decoration:underline;">Research Funding Agreement</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Effective March 1, 1997, Dr. Burzynski restructured his funding arrangement with the Company and entered into a Research Funding Agreement. Under this agreement the two parties agreed to the following:</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:35pt;"><p style="width:35pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 19.00pt;">
<p style="font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt;">
<font style="margin:0pt;font-family:Times New Roman,Times,serif;font-size:10pt;;"> 1.</font>
</p>
</td><td style="width:16pt;"><p style="width:16pt;width:16pt;font-size:0pt;"></p></td><td align="left" valign="top">
<p style="font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt;">
<font style="display:inline;font-size:10pt;">The Company agrees to undertake all scientific research in connection with the development of new or improved Antineoplastons for the treatment of cancer. The Company will hire such personnel as is required to fulfill its obligations under the agreement.</font></p></td></tr></table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:35pt;"><p style="width:35pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 19.00pt;">
<p style="font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt;">
<font style="margin:0pt;font-family:Times New Roman,Times,serif;font-size:10pt;;"> 2.</font>
</p>
</td><td style="width:16pt;"><p style="width:16pt;width:16pt;font-size:0pt;"></p></td><td align="left" valign="top">
<p style="font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt;">
<font style="display:inline;font-size:10pt;">Dr. Burzynski agrees to fund in its entirety all basic research, which the Company undertakes in connection with the development of other Antineoplastons or refinements to existing Antineoplastons for the treatment of cancer.</font></p></td></tr></table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:35pt;"><p style="width:35pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 19.00pt;">
<p style="font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt;">
<font style="margin:0pt;font-family:Times New Roman,Times,serif;font-size:10pt;;"> 3.</font>
</p>
</td><td style="width:16pt;"><p style="width:16pt;width:16pt;font-size:0pt;"></p></td><td align="left" valign="top">
<p style="font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt;">
<font style="display:inline;font-size:10pt;">As FDA approval of Antineoplastons will benefit both parties, Dr. Burzynski agrees to pay the expenses to conduct the clinical trials for the Company.</font></p></td></tr></table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:35pt;"><p style="width:35pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 19.00pt;">
<p style="font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt;">
<font style="margin:0pt;font-family:Times New Roman,Times,serif;font-size:10pt;;"> 4.</font>
</p>
</td><td style="width:16pt;"><p style="width:16pt;width:16pt;font-size:0pt;"></p></td><td align="left" valign="top">
<p style="font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt;">
<font style="display:inline;font-size:10pt;">Dr. Burzynski agrees to provide the Company such laboratory and research space as the Company needs at the Trinity Drive facility in Stafford, Texas, and such office space as is necessary at Trinity Drive and at his medical facility.</font></p></td></tr></table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:35pt;"><p style="width:35pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 19.00pt;">
<p style="font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt;">
<font style="margin:0pt;font-family:Times New Roman,Times,serif;font-size:10pt;;"> 5.</font>
</p>
</td><td style="width:16pt;"><p style="width:16pt;width:16pt;font-size:0pt;"></p></td><td align="left" valign="top">
<p style="font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt;">
<font style="display:inline;font-size:10pt;">In the event the research described in the agreement results in the approval of any additional patents for the treatment of cancer, Dr. Burzynski shall own all such patents, but shall license to the Company the patents based on the same terms, conditions and limitations as is in the current license between the parties.</font></p></td></tr></table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:35pt;"><p style="width:35pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 19.00pt;">
<p style="font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt;">
<font style="margin:0pt;font-family:Times New Roman,Times,serif;font-size:10pt;;"> 6.</font>
</p>
</td><td style="width:16pt;"><p style="width:16pt;width:16pt;font-size:0pt;"></p></td><td align="left" valign="top">
<p style="font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt;">
<font style="display:inline;font-size:10pt;">Dr. Burzynski shall have unlimited and free access to all equipment which the Company owns, so long as such use is not in conflict with the Company’s use of such equipment, including without limitation to all equipment used in manufacturing of Antineoplastons used in the clinical trials.</font></p></td></tr></table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:35pt;"><p style="width:35pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 19.00pt;">
<p style="font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt;">
<font style="margin:0pt;font-family:Times New Roman,Times,serif;font-size:10pt;;"> 7.</font>
</p>
</td><td style="width:16pt;"><p style="width:16pt;width:16pt;font-size:0pt;"></p></td><td align="left" valign="top">
<p style="font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt;">
<font style="display:inline;font-size:10pt;">The amounts, which Dr. Burzynski is obligated to pay under the agreement, shall be reduced dollar for dollar by the following:</font></p></td></tr></table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 72pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">a.Any income which the Company receives for services provided to other companies for research and/or development of other products, less such identifiable marginal or additional expenses necessary to produce such income (such as the purchase of chemicals, products or equipment) solely necessary to engage in such other research and development activity, and</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 72pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">b.The net proceeds of any stock offering or private placement, which the Company receives during the term of the engagement up to a maximum of $1,000,000 in a given Company fiscal year.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:35pt;"><p style="width:35pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 19.00pt;">
<p style="font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt;">
<font style="margin:0pt;font-family:Times New Roman,Times,serif;font-size:10pt;;"> 8.</font>
</p>
</td><td style="width:16pt;"><p style="width:16pt;width:16pt;font-size:0pt;"></p></td><td align="left" valign="top">
<p style="font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt;">
<font style="display:inline;font-size:10pt;">Effective March 1, 2017, the term of the Research Funding Agreement was extended to February 28, 2018, and is automatically renewable for an additional one-year term thereafter, unless one party notifies the other party at least thirty days prior to the expiration of the term of the agreement of its intention not to renew the agreement. In addition to the foregoing termination provisions, the agreement automatically terminates in the event that Dr. Burzynski owns less than fifty percent of the outstanding shares of the Company, or is removed as President and/or Chairman of the Board of the Company, unless Dr. Burzynski notifies the Company in writing of his intention to continue the agreement notwithstanding this automatic termination provision.</font></p></td></tr></table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;text-indent:35.45pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;text-decoration:underline;">Royalty Agreement</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company entered into a royalty agreement with Dr. Burzynski whereby upon receiving FDA approval for interstate marketing and distribution, the Company agrees to pay Dr. Burzynski a royalty interest equivalent to 10% of the Company’s gross income, which royalty interest shall include gross receipts from all future sales, distributions and manufacture of Antineoplastons. Dr. Burzynski will have the right to either produce Antineoplaston products for use in his medical practice to treat up to 1,000 patients without paying any fees to the Company, or purchase from the Company Antineoplaston products for use in his medical practice to treat up to 1,000 patients at a price of the Company’s cost to produce the Antineoplaston products plus 10%. Dr. Burzynski will also have the right to either lease or purchase all the manufacturing equipment located at 12707 Trinity Drive, Stafford, Texas at a fair market price. The Company will also have the right to lease from Dr. Burzynski the entire premise located at 12707 Trinity Drive, Stafford, Texas at arms-length terms at rates competitive with those available in the market at that time, provided that Dr. Burzynski does not need the facility for his use.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The term of this agreement is indefinite and will continue until such time as both parties agree it is not in their mutual interest to continue.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;text-indent:35.45pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;text-decoration:underline;">Other Related Party Transactions</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Dr. Burzynski owns the production facility located at Trinity Drive. There is no formal lease agreement between Dr. Burzynski and the Company; however, the Research Funding Agreement described above provides that Dr. Burzynski will allow the Company the use of the building. In addition, the Royalty Agreement states that after FDA approval is granted (though approval is not assured) the Company may rent the facility at competitive rates if Dr. Burzynski does not need the facility for his use. The actual facility costs are included in the financial statements as set forth in Note 5. In addition, Dr. Burzynski’s medical clinic performs certain administrative functions such as accounting, and allows the Company the use of some office space. Since May of 2000, Dr. Burzynski’s entire salary is paid through his medical practice and he is not compensated directly by the Company for his services.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company has received all significant funding from Dr. Burzynski through either cash contributed to the Company or the payment of the cost to conduct FDA approved clinical trials through his medical practice, as disclosed in Note 1. Following is a summary of the capital contributed and clinical trial costs paid by Dr. Burzynski for the years ended February 28, 2018 and 2017, respectively:</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 86.00%;margin-left:36pt;">
<tr>
<td valign="bottom" style="width:65.40%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-size:8pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">2018</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">2017</font></p>
</td>
<td valign="bottom" style="width:01.14%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.14%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Capital contributed</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.56%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>319,268
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.56%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>311,943
</td>
<td valign="bottom" style="width:01.14%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.14%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Clinical trial costs paid direct</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.56%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,218,134
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.56%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,260,791
</td>
<td valign="bottom" style="width:01.14%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
</table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
1324961
1280470
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;text-indent:35.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-style:italic;font-size:10pt;">Research and Development</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Research and development cost are charged to operations in the period incurred. Equipment used in research and development activities, which have alternative uses, is capitalized.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
10000
-118773529
-120385630
0
0
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;"><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font></font>
</p>
<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 86.00%;margin-left:36pt;">
<tr>
<td valign="bottom" style="width:65.40%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-size:8pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">2018</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">2017</font></p>
</td>
<td valign="bottom" style="width:01.16%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Expected benefit</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.54%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(338,541
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">)</font></p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.54%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(511,604
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">)</font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Effect of expenses deducted directly by Dr. Burzynski</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>338,541
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>511,604
</td>
<td valign="bottom" style="width:01.16%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Other adjustments</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(60,630
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">)</font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>23,128
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Change in valuation allowance</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>60,630
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(23,128
</td>
<td valign="bottom" style="width:01.16%;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">)</font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.16%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Income tax expense</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.54%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.54%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
</tr>
</table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;"><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font></font>
</p>
<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 86.00%;margin-left:36pt;">
<tr>
<td valign="bottom" style="width:65.40%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-size:8pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">2018</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">2017</font></p>
</td>
<td valign="bottom" style="width:01.16%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Deferred tax assets:</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Net operating loss carryforwards</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.54%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>138,969
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.54%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>199,599
</td>
<td valign="bottom" style="width:01.16%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Excess book (tax) depreciation</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Accrued expenses</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:01.16%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Alternative minimum tax credit carryforwards</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>42,603
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>42,603
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Total deferred tax assets</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>181,572
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>242,202
</td>
<td valign="bottom" style="width:01.16%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Less valuation allowance</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(181,572
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">)</font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(242,202
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">)</font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Net deferred tax assets</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.54%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.54%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:01.16%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
<td valign="bottom" style="width:01.16%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
<font style="display:inline;font-size:1pt;"> </font></p>
</td>
</tr>
</table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;"><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font></font>
</p>
<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 86.00%;margin-left:36pt;">
<tr>
<td valign="bottom" style="width:65.40%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-size:8pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">2018</font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
<font style="display:inline;font-weight:bold;font-size:8pt;">2017</font></p>
</td>
<td valign="bottom" style="width:01.14%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.14%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Capital contributed</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.56%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>319,268
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.56%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>311,943
</td>
<td valign="bottom" style="width:01.14%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font></p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:02.88%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td colspan="2" valign="bottom" style="width:13.84%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.14%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:65.40%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Clinical trial costs paid direct</font></p>
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.56%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,218,134
</td>
<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:12.56%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,260,791
</td>
<td valign="bottom" style="width:01.14%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
</table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;"><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font></font>
</p>
<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 53.00%;margin-left:126pt;">
<tr>
<td valign="top" style="width:43.76%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">400,000 options</font></p>
</td>
<td valign="top" style="width:56.26%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">September 14, 1996</font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:43.76%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">100,000 options</font></p>
</td>
<td valign="top" style="width:56.26%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">June 1, 1997</font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:43.76%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">100,000 options</font></p>
</td>
<td valign="top" style="width:56.26%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">June 1, 1998</font></p>
</td>
</tr>
</table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
600000
400000
100000
100000
0
0
0.35
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-style:italic;font-size:10pt;">Stock Options and Warrants</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company accounts for stock-based compensation under the provisions of FASB ASC 718, </font><font style="display:inline;font-style:italic;font-size:10pt;">“Compensation — Stock Compensation,”</font><font style="display:inline;font-size:10pt;"> which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees and non-employee officers based on estimated fair values as of the date of grant. Compensation expense is recognized on a straight-line basis over the requisite service period.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company accounts for share-based payments to non-employees, with guidance provided by FASB ASC 505-50, “</font><font style="display:inline;font-style:italic;font-size:10pt;">Equity-Based Payments to Non-Employees</font><font style="display:inline;font-size:10pt;">.”</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The Company did not grant any options and no options previously granted vested in any of the periods presented in these financial statements. Thus, there was no effect on net loss and earnings per share regarding the provisions of FASB ASC 718 or FASB 505-50 in any of the periods presented.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
131448444
131448444
131448444
-101018
117036345
131449
-117268812
-33001
118609079
131449
-118773529
-107700
120146481
131449
-120385630
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-size:10pt;">7.</font><font style="display:inline;font-size:3pt;"> </font><font style="display:inline;font-weight:bold;font-size:10pt;">Equity Transactions:</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.3pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">On September 14, 1996, the Company granted 600,000 stock options, with an exercise price of $0.35 per share, to an officer who is no longer with the Company. The options vested as follows:</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 53.00%;margin-left:126pt;">
<tr>
<td valign="top" style="width:43.76%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">400,000 options</font></p>
</td>
<td valign="top" style="width:56.26%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">September 14, 1996</font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:43.76%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">100,000 options</font></p>
</td>
<td valign="top" style="width:56.26%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">June 1, 1997</font></p>
</td>
</tr>
<tr>
<td valign="top" style="width:43.76%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">100,000 options</font></p>
</td>
<td valign="top" style="width:56.26%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">June 1, 1998</font></p>
</td>
</tr>
</table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The options are valid in perpetuity. None of the options have been exercised as of February 28, 2018.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">On June 1, 2009, the Company approved the issuance of 60,000 shares of the Company’s Common Stock as compensation for services rendered to the Company and were fair valued at approximately $9,400. The shares were sold pursuant to an exemption from registration under Section 4(2) of the Securities Act of 1933, as amended, to a single accredited investor and did not involve a public offering.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">Effective July 5, 2012, the Company entered into a Marketing and Consulting Agreement (the “Marketing Agreement”) with Worldwide Medical Consultants, Inc. (“WMC”) and CARIGEN, LTD (“SRB”), an entity wholly-owned and controlled by Dr. Burzynski, pursuant to which WMC will (i) provide SRB with various marketing and consulting services to assist SRB in locating and developing cancer or health related centers in certain foreign markets and (ii) make payments to the Company equal to 10% of each consulting fee received by WMC for the aforementioned services provided to SRB, net of certain expenses incurred by WMC (“WMC Payment”). In consideration of the WMC Payment, the Company agreed to grant to WMC warrants to acquire an aggregate of 2,000,000 shares of the Company’s Common Stock, exercisable at $0.10 per share with a ten year exercise period, with 1,000,000 shares vesting upon execution of the agreement and the remaining 1,000,000 shares to vest upon the first closing of a transaction by SRB as a result of the services provided by WMC under the Marketing Agreement. The fair market value of the vested warrants as of the date of grant was measured using the Black-Scholes option pricing model and totaled approximately $160,000 or $0.16 per warrant. As of February 28, 2018, none of the aforementioned warrants have been exercised and no additional vesting has occurred.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
60000
0
9400
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The net operating loss carryforwards expire as of February 28 or 29 of the following years:</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 35.00%;margin-left:36pt;">
<tr>
<td valign="top" style="width:32.04%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2022</font></p>
</td>
<td valign="bottom" style="width:06.98%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,250
</td>
<td valign="bottom" style="width:05.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:32.04%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2023</font></p>
</td>
<td valign="bottom" style="width:06.98%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>73,401
</td>
<td valign="bottom" style="width:05.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:32.04%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2024</font></p>
</td>
<td valign="bottom" style="width:06.98%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>69,394
</td>
<td valign="bottom" style="width:05.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:32.04%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2025</font></p>
</td>
<td valign="bottom" style="width:06.98%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>13,475
</td>
<td valign="bottom" style="width:05.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:32.04%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2026</font></p>
</td>
<td valign="bottom" style="width:06.98%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>46,972
</td>
<td valign="bottom" style="width:05.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:32.04%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2027</font></p>
</td>
<td valign="bottom" style="width:06.98%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>31,220
</td>
<td valign="bottom" style="width:05.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:32.04%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2028</font></p>
</td>
<td valign="bottom" style="width:06.98%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,737
</td>
<td valign="bottom" style="width:05.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="top" style="width:32.04%;padding:0pt;">
<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2029</font></p>
</td>
<td valign="bottom" style="width:06.98%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>31,868
</td>
<td valign="bottom" style="width:05.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:32.04%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2030</font></p>
</td>
<td valign="bottom" style="width:06.98%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:05.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:32.04%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2031</font></p>
</td>
<td valign="bottom" style="width:06.98%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:05.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:32.04%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2032</font></p>
</td>
<td valign="bottom" style="width:06.98%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:05.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:32.04%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2033</font></p>
</td>
<td valign="bottom" style="width:06.98%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>207,097
</td>
<td valign="bottom" style="width:05.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:32.04%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2034</font></p>
</td>
<td valign="bottom" style="width:06.98%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>76,643
</td>
<td valign="bottom" style="width:05.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:32.04%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2035</font></p>
</td>
<td valign="bottom" style="width:06.98%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:05.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:32.04%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2036</font></p>
</td>
<td valign="bottom" style="width:06.98%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">—</font></p>
</td>
<td valign="bottom" style="width:05.12%;background-color: #CCEEFF;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
<tr>
<td valign="bottom" style="width:32.04%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">2037</font></p>
</td>
<td valign="bottom" style="width:06.98%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
<td valign="bottom" style="width:03.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">$</font></p>
</td>
<td valign="bottom" style="width:52.74%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>74,699
</td>
<td valign="bottom" style="width:05.12%;padding:0pt;">
<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 12pt;">
</p>
</td>
</tr>
</table></div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
0
0
<div> <div>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt;text-indent:35.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-weight:bold;font-style:italic;font-size:10pt;">Management Estimates</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p>
<p style="margin:0pt 0pt 0pt 35.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reported periods. The significant estimates are the allocation of payroll and other expenses between the clinical trial expenses reported with BRI and Dr. Burzynski’s medical practice expenses. Department managers review at least quarterly the duties of each employee in their department and estimate the percentage of time each employee spends between clinical trials and the medical practice. Payroll costs are allocated between clinical trials and the medical practice based on these percentages. Other expenses are allocated based on the percentage of payroll allocated to either clinical trials or the medical practice. Management believes that the estimates and allocations are reasonable. Actual results could differ from these estimates.</font>
</p>
<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
<font style="display:inline;font-size:10pt;"> </font>
</p><div /></div> </div>
160000
131448444
131448444